Overview

Anti-suicidal Effects of Buprenorphine In Depressed Individuals

Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
This study aims to examine the effect of low-dose buprenorphine as an add-on to treatment-as-usual for suicidal ideation in individuals with major depression, and investigate the functional brain activity related to its potential anti-suicidal effect.
Phase:
Phase 3
Details
Lead Sponsor:
New York State Psychiatric Institute
Treatments:
Buprenorphine